AstraZeneca and Merck Establish Strategic Oncology Partnership, page-3

I am interested to find out. Have sent the link to the company and asked whether it would be worth making an announcement about the implications. Maybe they read their web mail(?). Could well be interested in developing drugs around different cell pathways (my understanding of the science is superficial). They may concentrate on their joint developments and leave VLA dangling. Or having established this JV use it to deal with VLA. I will wait for the pronouncements of wiser heads.